Nomenclature for Factors of the HLA System, 1994
1994; Wiley; Volume: 67; Issue: 4 Linguagem: Inglês
10.1111/j.1423-0410.1994.tb01287.x
ISSN1423-0410
AutoresJulia G. Bodmer, Steven G. E. Marsh, E. D. Albert, Walter F. Bodmer, Bo Dupont, M Kellis, Bernard Mach, Wolfgang R. Mayr, Peter Parham, Takehiko Sasazuki, Geziena M. Th. Schreuder, Jack L. Strominger, Arne Svejgaard, Paul I. Terasaki,
Tópico(s)Blood groups and transfusion
ResumoVox SanguinisVolume 67, Issue 4 p. 412-430 Nomenclature for Factors of the HLA System, 1994 Julia G. Bodmer, Corresponding Author Julia G. BodmerImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorSteven G. E. Marsh, Steven G. E. Marsh Tissue Antigen Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX (UK) Telephone: 44 (UK)-71 (London) - 269–3534 FAX: 44 (UK) - 71 (London) - 831–6786Search for more papers by this authorEkkehard D. Albert, Corresponding Author Ekkehard D. AlbertImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorWalter F. Bodmer, Corresponding Author Walter F. BodmerImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorBo Dupont, Corresponding Author Bo DupontImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorHenry A. Erlich, Corresponding Author Henry A. ErlichImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorBernard Mach, Corresponding Author Bernard MachImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorWolfgang R. Mayr, Corresponding Author Wolfgang R. MayrImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorPeter Parham, Corresponding Author Peter ParhamImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorTakehiko Sasazuki, Corresponding Author Takehiko SasazukiImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorGeziena M. Th. Schreuder, Corresponding Author Geziena M. Th. SchreuderImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorJack L. Strominger, Corresponding Author Jack L. StromingerImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorArne Svejgaard, Corresponding Author Arne SvejgaardImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorPaul I. Terasaki, Corresponding Author Paul I. TerasakiImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this author Julia G. Bodmer, Corresponding Author Julia G. BodmerImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorSteven G. E. Marsh, Steven G. E. Marsh Tissue Antigen Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX (UK) Telephone: 44 (UK)-71 (London) - 269–3534 FAX: 44 (UK) - 71 (London) - 831–6786Search for more papers by this authorEkkehard D. Albert, Corresponding Author Ekkehard D. AlbertImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorWalter F. Bodmer, Corresponding Author Walter F. BodmerImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorBo Dupont, Corresponding Author Bo DupontImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorHenry A. Erlich, Corresponding Author Henry A. ErlichImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorBernard Mach, Corresponding Author Bernard MachImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorWolfgang R. Mayr, Corresponding Author Wolfgang R. MayrImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorPeter Parham, Corresponding Author Peter ParhamImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorTakehiko Sasazuki, Corresponding Author Takehiko SasazukiImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorGeziena M. Th. Schreuder, Corresponding Author Geziena M. Th. SchreuderImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorJack L. Strominger, Corresponding Author Jack L. StromingerImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorArne Svejgaard, Corresponding Author Arne SvejgaardImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this authorPaul I. Terasaki, Corresponding Author Paul I. TerasakiImperial Cancer Research Fund 44 Lincoln's Inn Fields London WC2A 3PX (UK)Search for more papers by this author First published: November 1994 https://doi.org/10.1111/j.1423-0410.1994.tb01287.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 WHO Nomenclature Committee. Bull World Health Org 1968; 39: 483. PubMedGoogle Scholar 2 WHO Nomenclature Committee. WHO terminology report; in PI Terasaki (ed): Histocompatibility Testing, 1970. Copenhagen. Munks-gaard, 1970, p 49. Google Scholar 3 WHO Nomenclature Committee. Bull World Health Org 1972; 47: 659. PubMedGoogle Scholar 4 WHO Nomenclature Committee. Bull World Health Org 1975; 52: 261. PubMedGoogle Scholar 5 WHO Nomenclature Committee. Bull World Health Org 1978; 56: 461. PubMedGoogle Scholar 6 WHO Nomenclature Committee: in PI Terasaki, (ed): Histocompatibility Testing, 1980. Los Angeles, UCLA Tissue Typing Laboratory, 1980, pp 18–20. Google Scholar 7 WHO Nomenclature Committee: Nomenclature for factors of the HLA system 1984: in ED Albert, MP Baur, WR Mayr, (eds): Histocompatibility Testing, 1984. Berlin, Springer, 1985, pp 4–8. Google Scholar 8 Bodmer WF, Albert E., Bodmer JG, Dupont B., Mach B., Mayr WR, Sasazuki T., Schreuder GMT, Svejgaard A., Terasaki PI. Nomenclature for factors of the HLA system, 1987; in B. Dupont (ed): Immunobiology of HLA. New York, Springer, 1989, pp 72–79. 10.1007/978-1-4612-3552-1_14 Google Scholar 9 Bodmer JG, Marsh SGE, Parham P., Erlich HA, Albert E., Bodmer WF, Dupont B., Mach B., Mayr WR, Sasasuki T., Schreuder GMT, Strom-inger JL, Svejgaard A., Terasaki PI: Nomenclature for factors of the HLA system, 1989. Tissue Antigens 1990; 35: 1–8. 10.1111/j.1399-0039.1990.tb01749.x PubMedWeb of Science®Google Scholar 10 Bodmer JG, Marsh SGE, Albert E., Bodmer WF, Dupont B., Erlich HA, Mach B., Mayr WR, Par-ham P., Sasasuki T., Schreuder GMT, Strominger JL, Svejgaard A., Terasaki PI: Nomenclature for factors of the HLA system, 1990. Tissue Antigens 1991; 37: 97–104. 10.1111/j.1399-0039.1991.tb01853.x PubMedWeb of Science®Google Scholar 11 Bodmer JG, Marsh SGE, Albert E., Bodmer WF, Dupont B., Erlich HA, Mach B., Mayr WR, Par-ham P., Sasasuki T., Schreuder GMT, Strominger JL, Svejgaard A., Terasaki PI: Nomenclature for factors of the HLA system, 1991; in T. Tsuji, M. Ai-zawa, T. Sasazuki (eds): HLA 1991. Oxford, Oxford University Press, 1992, pp 17–31 Google Scholar 12 Geraghty DE, Koller BH, Pei J., Hansen JA: Examination of four HLA Class I pseudogenes. Common events in the evolution of HLA genes and pseudogenes. J Immunology 1992; 149: 1947–1956. CASPubMedWeb of Science®Google Scholar 13 Krangel MS: Unusual RNA splicing generates a secreted form of HLA-A2 in a mutagenized B lymphoblastoid cell line. EMBO J 1985; 4: 1205–1210. 10.1002/j.1460-2075.1985.tb03761.x CASPubMedWeb of Science®Google Scholar 14 Belich MP, Madrigal JA, Hildebrand WH, Zem-mour J., Williams RC, Luz R., Petzl-Erler ML, Parham P.: Unusual HLA-B alleles in two tribes of Brazilian Indians. Nature 1992; 357: 326–329. 10.1038/357326a0 CASPubMedWeb of Science®Google Scholar 15 Barber DF, Fernandez JM, Guttridge MG, López de Castro JA: Primary structure of a new HLA-A2 subtype: HLA-A *0213. Immunoge-netics 1994; 39: 378. 10.1007/BF00189243 CASPubMedWeb of Science®Google Scholar 16 Lin L., Tokunaga K., Ishikawa Y., Bannai MH, Kashiwase K., Kuwata S., Akaza T., Tadokoro K., Shibata Y., Juji T.: Sequence analysis of serological HLA-A11 split antigens, A11.1 and A11.2. Tissue Antigens 1994; 43: 78–82. 10.1111/j.1399-0039.1994.tb02304.x CASPubMedWeb of Science®Google Scholar 17 Madrigal JA, Hildebrand WH, Belich MP, Benjamin RJ, Little AM, Zemmour J., Ennis PD, Ward FE, Petzl-Erler ML, du Toit ED, Parham P.: Structural diversity in the HLA-A10 family of alleles: Correlations with serology. Tissue Antigens 1993; 41: 72–80. 10.1111/j.1399-0039.1993.tb01982.x CASPubMedWeb of Science®Google Scholar 18 Ishikawa Y., Tokunaga K., Lin L., Imanishi T., Sai-tou S., Kimura A., Kashiwase K., Akaza T., Tadokoro K., Juji T.: Sequences of four splits of HLA-A10 group: Implications for serological cross-reactivities and their evolution. Hum Immunol 1994; 39: 220–224. 10.1016/0198-8859(94)90263-1 CASPubMedWeb of Science®Google Scholar 19 Olerup O., Daniels T., Baxter-Lowe LA: Correction of the A*3001 sequence. Tissue Antigens, in press. Google Scholar 20 Choo SY, Starling GC, Anasetti C., Hansen JA: Selection of an unrelated donor for marrow transplantation facilitated by the molecular characterisation of a novel HLA-A allele. Hum Immunol 1993; 36: 20–26. 10.1016/0198-8859(93)90004-K CASPubMedWeb of Science®Google Scholar 21 Kato N., Kikuchi A., Kano K., Egawa K., Takigu-chi M.: Molecular analysis of a novel HLA-A33 subtype associated with HLA-B44. Tissue Antigens 1993; 41: 211–213. 10.1111/j.1399-0039.1993.tb02006.x CASPubMedWeb of Science®Google Scholar 22 Schnable E., Stockinger H., Madjic O., Gaugitsch H., Lindley IJD, Maurer D., Hajek-Rosenmayr A., Knapp W.: Activated human T lymphocytes express MHC Class 1 heavy chains not associated with β2-microglobulin. J Exp Med 1990; 171: 1431–1442. 10.1084/jem.171.5.1431 CASPubMedWeb of Science®Google Scholar 23 Domena JD, Hildebrand WH, Bias WB, Parham P.: A sixth family of HLA-A alleles defined by A*8001. Tissue Antigens 1993; 42: 156–159. 10.1111/j.1399-0039.1993.tb02186.x CASPubMedWeb of Science®Google Scholar 24 Wagner AG, Hughes AL, Iandoli ML, Stewart D., Herbert S., Watkins DI, Hurley CK, Rosen-Bronson S.: HLA-A*8001 is a member of a newly discovered ancient family of HLA-A alleles. Tissue Antigens 1993; 42: 522–529. 10.1111/j.1399-0039.1993.tb02198.x CASPubMedWeb of Science®Google Scholar 25 Starling GC, Witkowski JA, Speerbrecher LS, McKinney SK, Hansen JA, Choo SY: A novel HLA-A*8001 allele identified in African American population. Hum Immunol 1994; 39: 163–168. 10.1016/0198-8859(94)90256-9 CASPubMedWeb of Science®Google Scholar 26 Domena JD, Azumi K., Bias WB, Parham P.: B* 1401 encodes the B64 antigen: the B64 and B65 splits of B14 differ only at residue 11, a buried amino acid. Tissue Antigens 1993; 41: 110–111. 10.1111/j.1399-0039.1993.tb01989.x CASPubMedWeb of Science®Google Scholar 27 Domena JD, Little A-M, Arnett KL, Adams EJ, Marsh SGE, Parham P.: A small test of a sequence-based typing method: Definition of the B* 1520 allele. Tissue Antigens, in press. Google Scholar 28 Choo SY, Fan LA, Hansen JA: Allelic variations clustered in the antigen binding sites of HLA-Bw62 molecules. Immunogenetics 1993; 37: 108–113. CASPubMedWeb of Science®Google Scholar 29 Hildebrand WH, Domena JD, Shen SY, Lau M., Terasaki P., Bunce M., Marsh SGE, Guttridge MG, Bias WB, Parham P.: HLA-B 15: A widespread and diverse family of HLA-B alleles. Tissue Antigens 1994; 43: 209–218. 10.1111/j.1399-0039.1994.tb02327.x CASPubMedWeb of Science®Google Scholar 30 Domena JD, Little AM, Madrigal AJ, Hildebrand WH, Johnston-Dow L., du Toit E., Bias WB, Parham P.: Structural heterogeneity in HLA-B70, a high frequency antigen of Black populations. Tissue Antigens 1993; 42: 509–517. 10.1111/j.1399-0039.1993.tb02196.x CASPubMedWeb of Science®Google Scholar 31 Rodriguez SG, Johnson AH, Hurley CK: Molecular characterisation of HLA-B71 from an African American Individual. Hum Immunol 1993; 37: 192–194. 10.1016/0198-8859(93)90185-4 CASPubMedWeb of Science®Google Scholar 32 Choo SY, Fan LA, Hansen JA: A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the α1 domain. J Immunol 1991; 147: 174–180. CASPubMedWeb of Science®Google Scholar 33 Seemann GH, Rein RS, Brown CS, Ploegh HL: Gene conversion-like mechanisms may generate polymorphism in human class I genes. EMBO J 1986; 5: 547–52. 10.1002/j.1460-2075.1986.tb04245.x CASPubMedWeb of Science®Google Scholar 34 Weiss EH, Kuon W., Dörner C., Lang M., Rieth-müller G.: Organization, sequence and expression of the HLA-B27 gene: A molecular approach to analyze HLA and disease associations. Immunobiology 1985; 170: 367–380. 10.1016/S0171-2985(85)80061-9 CASPubMedWeb of Science®Google Scholar 35 Coppin HL, McDevitt HO: Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients. J Immunol 1986; 137: 2168–2172. PubMedWeb of Science®Google Scholar 36 Szöts H., Riethmüller G., Weiss E., Meo T.: Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic series. Proc Natl Acad Sci USA 1986; 83: 1428–1432. 10.1073/pnas.83.5.1428 CASPubMedWeb of Science®Google Scholar 37 Watkins DI, McAdam SN, Liu X., Strang CR, Milford EL, Levine CG, Garber TL, Dogon AL, Lord CI, Ghim SH, Troup GM, Hughes AL, Letvin NL: New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class 1 loci. Nature 1992; 357: 329–333. 10.1038/357329a0 CASPubMedWeb of Science®Google Scholar 38 Vilches C., de Pablo R., Kreisler M.: Nucleotide sequence of B*2706. Immunogenetics 1994; 39: 219. 10.1007/BF00241265 CASPubMedWeb of Science®Google Scholar 39 Hildebrand WH, Domena JD, Shen SY, Marsh SGE, Bunce M., Darke C., Parham P.: The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27. Tissue Antigens, in press. Google Scholar 40 Theiler G., Pando M., Delfino JM, Takiguchi M., Satz ML: Isolation and characterisation of two new functional subtypes of HLA-B35. Tissue Antigens 1993; 41: 143–147. 10.1111/j.1399-0039.1993.tb01993.x CASPubMedWeb of Science®Google Scholar 41 Steinle A., Reinhardt C., Nössner E., Uchanska-Ziegler B., Ziegler A., Schendel D.: Natural mi-croheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-re-stricted monoclonal antibody. Hum Immunol 1994; 38: 261–269. 10.1016/0198-8859(93)90553-D CASWeb of Science®Google Scholar 42 Little AM, Domena JD, Hildebrand WH, Shen SY, Barber LD, Marsh SGE, Bias WB, Parham P.: HLA-B67: A member of the HLA-B16 family that expresses the ME1 epitope. Tissue Antigens 1994; 43: 38–43. 10.1111/j.1399-0039.1994.tb02294.x CASPubMedWeb of Science®Google Scholar 43 Muller CA, Engler BG, Gekeler V., Steiert I., Weiss E., Schmidt H.: Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 1989; 30: 200–207. 10.1007/BF02421207 CASPubMedWeb of Science®Google Scholar 44 Kato N., Karaki S., Kashiwase K., Müller C., Aka-za T., Juji T., Kano K., Takiguchi M.: Molecular Analysis of HLA-B39 subtypes. Immunogenetics 1993; 37: 212–216. 10.1007/BF00191887 CASPubMedWeb of Science®Google Scholar 45 Ways JP, Lawlor DA, Wan AM, Parham P.: A transposable epitope of HLA-B7, B40 molecules. Immunogenetics 1987; 25: 323–328. 10.1007/BF00404425 CASPubMedWeb of Science®Google Scholar 46 Kawaguchi G., Kato N., Kashiwase K., Karaki S., Kohsaka T., Akaza T., Kano K., Takiguchi M.: Structural analysis of HLA-B40 epitopes. Hum Immunol 1993; 36: 193–198. 10.1016/0198-8859(93)90125-K CASPubMedWeb of Science®Google Scholar 47 Domena JD, Johnston-Dow L., Parham P.: The B*4002 allele encodes the B61 antigen: B40* is identical to B61. Tissue Antigens 1992; 40: 254–256. 10.1111/j.1399-0039.1992.tb02053.x CASPubMedWeb of Science®Google Scholar 48 Keever CA, Leong N., Cunningham I., Copelan EA, Avalos BR, Klein J., Kapoor N., Adams PW, Orosz CG, Tutschka PJ, Baxter-Lowe LA: HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 1994; 13, in press. Google Scholar 49 Yao Z., Keller E., Scholz S., McNicolas A., Volg-ger A., Albert ED: Identification of two major HLA-B44 subtypes and a novel B44 sequence: Oligotyping and solid phase sequencing of PCR products. Hum Immunol 1994, in press. Google Scholar 50 Gauchat-Feiss D., Breur-Vriesendorp BS, Rufer N., Jeannet M., Rossnek E., Tiercy J-M: Sequencing of a novel functional HLA-B44 subtype differing in two residues in the alpha 2 domain, (B*4404). Tissue Antigens, in press. Google Scholar 51 Pohla H., Kuon W., Tabaczewski P., Doerner C., Weiss EH: Allelic variation in HLA-B and HLA-C sequences and the evolution of the HLA-B alleles. Immunogenetics 1989; 29: 297–307. 10.1007/BF00352839 CASPubMedWeb of Science®Google Scholar 52 Cereb N., Choi JW, Riu KZ, Yang SY: HLA-B*5105, a newly identified B51 IEF variant. Tissue Antigens, in press. Google Scholar 53 Hayashi H., Ennis PD, Ariga H., Salter RD, Parham P., Kano K., Takiguchi M.: HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the α1 domain. J Immunol 1989; 142: 306–311. CASPubMedWeb of Science®Google Scholar 54 Parham P., Arnett HK, Adams EJ, Barber LD, Domena J., Hildebrand WH, Little A-M: The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens, in press. Google Scholar 55 Hildebrand WH, Domena JD, Parham P.: Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8. Tissue Antigens 1993; 41: 190–195. 10.1111/j.1399-0039.1993.tb02001.x CASPubMedWeb of Science®Google Scholar 56 Vilches C., de Pablo R., Herrero MJ, Moreno ME, Kreisler M.: HLA-B73, an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27. Immunogenetics, in press. Google Scholar 57 Grassi F., Meneveri R., Gullberg M., Lopalco L., Rossi GB, Lanza P., de Santis C., Brattsand G., Buttò S., Ginelli E., Beretta A., Siccardi AG: Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by Class I major histocompatibility complex heavy chains. J Exp Med 1991; 174: 53–62. 10.1084/jem.174.1.53 CASPubMedWeb of Science®Google Scholar 58 Ellis SA, Strachan T., Palmer MS, McMichael AJ: Complete nucleotide sequence of a unique HLA Class I C locus product expressed on the human choriocarcinoma cell line BeWo. J Immunol 1989; 142: 3281–3285. CASPubMedWeb of Science®Google Scholar 59 Petersdorf EW, Stanley JF, Martin PJ, Hansen JA: Molecular diversity of the HLA-C locus in unrelated marrow transplantation. Tissue Antigens, in press. Google Scholar 60 Steinle A., Nossner E., Schendel D.: Isolation and characterisation of a genomic HLA-Cw6 clone. Tissue Antigens 1992; 39: 134–137. 10.1111/j.1399-0039.1992.tb01923.x CASPubMedWeb of Science®Google Scholar 61 Vilches C., de Pablo R., Herrero MJ, Moreno ME, Kreisler M.: Molecular cloning and Polymerase chain reaction-sequence-specific oligonucleotide detection of the allele encoding the novel allospecificity HLA-Cw6.2 (Cw*1502) in Spanish Gypsies. Hum Immunol 1993; 37: 259–263. 10.1016/0198-8859(93)90509-Y CASPubMedWeb of Science®Google Scholar 62 Davidson WF, Kress M., Khoury G., Jay G.: Comparison of HLA Class I gene sequences: Derivation of locus-specific oligonucleotides probes specific for HLA-A, HLA-B, and HLA-C genes. J Biol Chem 1985; 260: 13414–13423. CASPubMedWeb of Science®Google Scholar 63 Takiguchi M., Nishimura I., Hayashi H., Karaki S., Kariyone A., Kano K.: The structure and expression of genes encoding serologically undetected HLA-C locus antigens. J Immunol 1989; 143: 1372–1378. CASPubMedWeb of Science®Google Scholar 64 Cereb N., Choi JW, Lee S., Maye P., Kong Y., Yang SY: Identification of two new HLA-C alleles, Cw*1203 and Cw*1402, from the sequence analysis of seven HLA homozygous cell lines carrying HLA-C blank. Tissue Antigens, in press. Google Scholar 65 Cianetti L., Testa U., Scotto L., La VR, Simeone A., Boccoli G., Giannella G., Peschle C., Bonci-nelli E.: Three new class I HLA alleles: structure of mRNAs and alternative mechanisms of processing. Immunogenetics 1989; 29: 80–91. 10.1007/BF00395855 CASPubMedWeb of Science®Google Scholar 66 de Pable MR, Vilches C., Moreno ME, Kreisler M.: A novel HLA-C allele (Cw* 1504) related to the Cw6.2 phenotype. Immunogenetics 1993; 39: 79. 10.1007/BF00171805 Google Scholar 67 Vilches C., Herrero MJ, de Pablo ME, Bunce M., Kreisler M.: Molecular characterization of a novel, serologically detectable, HLA-C allele: Cw*1602. Hum Immunol 1994; 40: in press. Google Scholar 68 Geraghty DE, Koller BH, Orr HT: A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA 1987; 84: 9145–9149. 10.1073/pnas.84.24.9145 CASPubMedWeb of Science®Google Scholar 69 Shukla H., Swaroop A., Srivastava R., Weissman SM: The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression. Nucleic Acids Res 1990; 18: 2189. 10.1093/nar/18.8.2189 CASPubMedWeb of Science®Google Scholar 70 Morales P., Corell A., Martinez-Laso J., Martín-Villa JM, Varela P., Paz-Artal E., Allende LM, Arnaiz-Villena A.: Three new HLA-G alleles and their linkage disequilibria with HLA-A. Immunogenetics 1993; 38: 323–331. 10.1007/BF00210473 CASPubMedWeb of Science®Google Scholar 71 Ellis SA, Palmer MS, McMichael AJ: Human Trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol 1990; 144: 731–735. 10.4049/jimmunol.144.2.731 CASPubMedWeb of Science®Google Scholar 72 Pook MA, Woodcock V., Tassabehji M., Campbell RD, Summers CW, Taylor M., Strachan T.: Characterization of an expressible nonclassical Class I HLA gene. Hum Immunol 1992; 32: 102–109. 10.1016/0198-8859(91)90106-J Web of Science®Google Scholar 73 Hurley CK, Ziff BL, Silver J., Gregersen PK, Hartzman R., Johnson AH: Polymorphism of the HLA-DR1 haplotype in American Blacks. Identification of a DR1 b-chain determinant recognized in the mixed lymphocyte reaction. J Immunol 1988; 140: 4019–4023. CASPubMedWeb of Science®Google Scholar 74 Coppin HL, Avoustin P., Fabron J., Huchenq A., Garnier JM, Thomsen M., de Preval C.: Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele ‘DR-BON’. J Immunol 1988; 144: 984–989. PubMedWeb of Science®Google Scholar 75 Guignier F., Mercier B., Roz P., Ferec C., Saleun JP, Chatelain P.: A novel DRB1*01 allele (DRB1*0104). Tissue Antigens 1993; 42: 42–44. 10.1111/j.1399-0039.1993.tb02165.x CASPubMedWeb of Science®Google Scholar 76 Lock CB, So AKL, Welsh KI, Parkes JD, Trow-sdale J.: MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics 1988; 27: 449–455. 10.1007/BF00364432 CASPubMedWeb of Science®Google Scholar 77 Rosenlicht JW, Hartung K., Deicher H., Frey J.: A novel HLA–DRB1–DR2 allele associated with HLA mistyping. Immunogenetics 1993; 37: 479. 10.1007/BF00222476 CASPubMedWeb of Science®Google Scholar 78 Laforet M., Urlacher A., Tongio MM: A new HLA DR16 allele (DRB1*1604) with a short DR8 sequence. Tissue Antigens 1994; 43: 256–258. 10.1111/j.1399-0039.1994.tb02335.x Web of Science®Google Scholar 79 Bettinotti MP, McNicholas A., Keller E., Andreas A., Scholz S., Albert E.: DRB1*1605: a new DR2–DRB1 allele found in a German family. Immunogenetics 1994; 39: 300. 10.1007/BF00188799 CASPubMedWeb of Science®Google Scholar 80 Anholts JDH, Verduyn W., Parleviet J., Doxidis IIN, D'Amaro J., Giphart M., Persijn G., Schreuder GMT: Irregular PCR-SSO hybridisation patterns reveal seven new HLA-DRB1 alleles related to DR2, DR3, DR6, DR8 and DR11: implications for sequence specific priming. Hum Immunol, in press. Google Scholar 81 Gustafsson K., Wiman K., Emmoth E., Larhammar D., Bohme J., Hyldig NJ, Ronne H., Peterson PA, Rask L.: Mutations and selection in the generation of class II histocompatibility antigen polymorphism. EMBO J 1984; 3: 1655–1661. 10.1002/j.1460-2075.1984.tb02026.x CASPubMedWeb of Science®Google Scholar 82 Gorski J., Mach B.: Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity. Nature 1986; 322: 67–70. 10.1038/322067a0 CASPubMedWeb of Science®Google Scholar 83 Bell JI, Denney DJ, Foster L., Belt T., Todd JA, McDevitt HO: Allelic variation in the DR sub-region of the human major histocompatibility complex. Proc Natl Acad Sci USA 1987; 84: 6234–6238. 10.1073/pnas.84.17.6234 CASPubMedWeb of Science®Google Scholar 84 Todd JA, Bell JI, McDevitt HO: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604. 10.1038/329599a0 CASPubMedWeb of Science®Google Scholar 85 Horn GT, Bugawan TL, Long CM, Manos MM, Erlich HA: Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum Immunol 1988; 21: 249–263. 10.1016/0198-8859(88)90034-1 CASPubMedWeb of Science®Google Scholar 86 Eberle M., Baxter-Lowe LA: A silent mutation in HLA-DRB1*0301 can affect oligotyping. Tissue Antigens 1992; 40: 150–152. 10.1111/j.1399-0039.1992.tb02108.x CASPubMedWeb of Science®Google Scholar 87 Buyse I., Edmonds M. P., Bouillon R., Bex M., de Canck I., Marynen P., Cassiman JJ: Novel Class II HLA DRB1, DRB4 and DPB1 alleles found in the Belgian population. Immunogenetics 1993; 38: 380. 10.1007/BF00210483 CASPubMedWeb of Science®Google Scholar 88 Spies T., Sorrentino R., Boss JM, Okada K., Strominger JL: Structural organization of the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci USA 1985; 82: 5165–5169. 10.1073/pnas.82.15.5165 CASPubMedWeb of Science®Google Scholar 89 Andersson G., Larhammar D., Widmark E., Ser-venius B., Peterson PA, Rask L.: Class II genes of the Human Major Histocompatibility Complex. J Biol Chemistry 1987; 262: 8748–8758. CASPubMedWeb of Science®Google Scholar 90 Curtsinger JM, Hilden JM, Cairns JS, Bach FH: Evolutionary and genetic implications of sequence variation in two nonallelic HLA-DRβ-chain cDNA sequences. Proc Natl Acad Sci USA 1987; 84: 209–213. 10.1073/pnas.84.1.209 CASPubMedWeb of Science®Google Scholar 91 Gregersen PK, Goyert SM, Song QL, Silver J.: Microheterogeneity of HLA-DR4 haplotypes: DNA sequence analysis of LD‘KT2’ and LD ‘TAS’ haplotypes. Hum Immunol 1987; 19: 287–292. 10.1016/0198-8859(87)90046-2 CASPubMedWeb of Science®Google Scholar 92 Morales P., Martinez-Laso J., Martin-Villa JM, Corell A., Vicario JL, Varela P., Pérez-Aciego P., Arnaiz-Villena A.: High frequency of the HLA-DRB1*0405-(Dw15)-DQw8 haplotype in Spaniards and its relationship to diabetes susceptibility. Hum Immunol 1991; 32: 170–175. 10.1016/0198-8859(91)90053-C CASPubMedWeb of Science®Google Scholar 93 Petersdorf EW, Smith AG, Martin PJ, Hansen JA: HLA-DRB1 first domain sequence for a novel DR4 allele designated DRB1*0413. Tissue Antigens 1992; 40: 267–268. 10.1111/j.1399-0039.1992.tb02057.x CASPubMedWeb of Science®Google Scholar 94 Pile KD, Willcox N., Bell JI, Wordsworth BP: A novel HLA-DR4 allele (DRB1*0414) in a patient with myast
Referência(s)